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Abstract
Because poor sanitation is hypothesized as a major direct and indirect pathway of exposure
to antimicrobial resistance genes (ARGs), we sought to determine a) the prevalence of and
b) environmental risk factors for gut carriage of key ARGs in a pediatric cohort at high risk of
enteric infections due to poor water, sanitation, and hygiene (WASH) conditions. We investi-
gated ARGs in stool from young children in crowded, low-income settlements of Maputo,
Mozambique, and explored potential associations with concurrent enteric pathogen car-
riage, diarrhea, and environmental risk factors, including WASH. We collected stool from
120 children <14 months old and tested specimens via quantal, multiplex molecular assays
for common bacterial, viral, and protozoan enteric pathogens and 84 ARGs encoding poten-
tial resistance to 7 antibiotic classes. We estimated associations between ARG detection
(number and diversity detected) and concurrently-measured enteric pathogen carriage,
recently-reported diarrhea, and risk factors in the child’s living environment. The most com-
monly-detected ARGs encoded resistance to macrolides, lincosamides, and streptogramins
(100% of children); tetracyclines (98%); β-lactams (94%), aminoglycosides (84%); fluoro-
quinolones (48%); and vancomycin (38%). Neither concurrent diarrhea nor measured envi-
ronmental (including WASH) conditions were associated with ARG detection in adjusted
models. Enteric pathogen carriage and ARG detection were associated: on average, 18%
more ARGs were detected in stool from children carrying bacterial pathogens than those
without (adjusted risk ratio (RR): 1.18, 95% confidence interval (CI): 1.02, 1.37), with 16%
fewer ARGs detected in children carrying parasitic pathogens (protozoans, adjusted RR:
0.84, 95% CI: 0.71, 0.99). We observed gut ARGs conferring potential resistance to a range
of antibiotics in this at-risk cohort that had high rates of enteric infection, even among chil-
dren <14 months-old. Gut ARGs did not appear closely correlated with WASH, though
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environmental conditions were generally poor. ARG carriage may be associated with con-
current carriage of bacterial enteric pathogens, suggesting indirect linkages to WASH that
merit further investigation.
Introduction
Antimicrobial resistance (AR) is a major global health threat, with antimicrobial use and
resistance concurrently growing worldwide. From 2000–2010, antimicrobial use increased by
>30% globally, with the largest increases in low- and middle-income countries (LMICs), likely
due to the high burden of infectious diseases and the increased availability and reduced cost of
antimicrobials [1]. A recent birth cohort study of seven LMIC sites found 98% of infants were
exposed to antimicrobials by 6 months of age [2]. Antimicrobial use in LMICs may be high
due to both insufficient training or oversight into prescriber practices, ease of access and lack
of regulation of antimicrobial agents to avoid use outside of pharmaceutical and clinical set-
tings, and mass drug campaigns that include administration of antimicrobials to healthy
children [1,3,4]. Thus, selective pressure from human use of antimicrobials in LMICs is
increasing. However, evaluation and assessment of AR, and risk factors for antimicrobial-
resistant infections, in LMICs remains limited because of poor surveillance and insufficient
funding [1].
Emerging regional- and national-scale evidence suggests poor water, sanitation, and
hygiene (WASH)—directly and indirectly—facilitates the development and environmental
dispersion of AR organisms [5–8]. More directly, poor WASH conditions—especially poor
containment and treatment of AR organisms and their genes through the sanitation chain—
may facilitate the development of resistance and increase individual risks of exposure to AR
genes (ARGs) or AR (vs. susceptible) pathogens [6,7,9,10]. Indirectly, poor WASH conditions
result in children exposed to enteric pathogens more frequently and in potentially higher con-
centrations [11,12], increasing treatment with antibiotics or antimicrobials and thereby accel-
erating the development of AR [10].
However, the hypothesized environmental contributions to ARG exposures have not been
directly measured on local scales, especially in LMICs where poor WASH infrastructure may
be highly prevalent and of paramount concern [10,13]. Insufficient treatment of AR organisms
and ARGs at sewage or fecal sludge treatment plants, and persistence of antibiotics in the fecal
waste stream, put water sources and water-associated environmental transmission pathways at
particular risk of contamination [6,14–18]. Furthermore, many LMIC communities lack con-
sistent access to functional, safe management of human waste throughout the sanitation chain,
leading to environmental discharge of untreated wastes [19–21]. More than half of the world’s
population and their feces (and almost two-thirds in LMICs [19]) are managed in onsite sys-
tems [22] and 60% of the world uses unsafely-managed sanitation [20], bringing exposure
risks directly into the household or the peripheral environment. Carriage of bacterial enteric
pathogens, due to exposure to poor WASH conditions [11], may co-occur with AR either
because enteric bacteria carry ARGs or because ARGs may accompany diverse bacterial
exposures.
Methodologically, challenges exist to assessing the fate, transport, and burden of AR from
the environment to humans and its impact on human health. Culture-based methods remain
the standard for assessing phenotypic resistance of AR organisms in the environmental and
in the gut microbiome, and are widely used for surveillance and health impact assessments
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[13,23]. Scaling these methods to large studies is constrained by human and financial resources
[13]. Conversely, molecular approaches to ARG detection present the potential for high-
throughput screening. However, interpretation of ARG carriage is challenging, given limited
understanding of their background circulation and clinical implications without culture con-
firmation [23,24]. Molecular approaches are moving towards more accurate prediction of
phenotypic resistance [25]. Additionally, there is a need to understand concurrent ARG preva-
lence in environmental media like sewage, wastewater, soil, drinking water, and recreational
water, particularly in environments with high fecal contamination [9]. As a start, an in-depth
understanding of the background prevalence and risk factors for ARGs in human hosts in
these settings can characterize the epidemiology and potential for environmental measures to
prevent ARG transmission.
In order to evaluate direct and indirect links between poor WASH (environmental risk fac-
tors) and ARG transmission, we evaluated ARG prevalence and associations between total
number of ARGs detected (and diversity of ARGs detected) and 1) environmental risk factors
(direct links: e.g. poor sanitation); and 2) enteric pathogen carriage (indirect links), in children
born into a pathogen-rich, densely-populated urban environment in Maputo, Mozambique as
part of a larger health impact trial of sanitation [26]. The goals of this study were to: a) evaluate
the prevalence and diversity of ARGs in young children (<14 months old) in a low-income,
urban environment; b) assess risk factors for ARGs in these children; and c) compare ARG
outcome metrics of diversity and total genes from a qPCR array including pre-selected ARGs.
Use of a qPCR array with pre-selected ARGs enabled comparison of relative AR profiles
between children in varying environments. Results from this analysis can improve under-
standing of background circulation of ARGs in children in Mozambique and settings with
similarly poor infrastructure and high burdens of enteric infections, and of links between
environmentally-mediated risk factors and ARGs.
Methods
This study was nested within a subgroup of children enrolled from 2015–2017 in the Maputo
Sanitation (MapSan) trial in Maputo, Mozambique [26]. Briefly, the MapSan trial tested the
effects of a shared private sanitation intervention–pour-flush latrines with septic tanks and
soakaway pits–on child health as compared to existing poor sanitation. In this setting, sanita-
tion is shared at the compound level; compounds are groups of two or more houses that share
outdoor living space (and sanitation). Thus, this study was a sub-analysis that the original
MapSan study was not designed to explicitly evaluate. For this study, the first 60 stools (one
per child) analyzed for the MapSan study that were from children <14 months old enrolled
in MapSan control and intervention compounds in round 1 (February 2015 –February 2016,
pre-intervention) and the first 60 meeting the same criteria (that is, among new children born
into an intervention or control compound) in round 2 (March 2016-April 2017, 12 months
post-intervention) were selected (n = 120 stools total). Selection was purposefully split evenly
by group: 30 children per intervention or control group in each round. Enrollment age criteria
ensured children were born into compounds following any changes in sanitation conditions
associated with the intervention (if in that group). By design of this study and enrollment age
criteria, no children could be enrolled multiple times, but a compound could be enrolled mul-
tiple times. Statistical models addressed potential within-compound level of clustering using
random effects for the compound of the child. Enteric pathogens in stool specimens were
assessed by a multiplex RT-PCR assay (Luminex xTAG Gastrointestinal Pathogen Panel
(GPP)1, Luminex Corp, Austin, TX, USA). The GPP tests for 15 enteric pathogens: 9 bacteria
(Campylobacter, C. difficile, enterotoxigenic E. coli (ETEC), Shiga toxin-producing E. coli
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(STEC), E. coli O157, Salmonella, Shigella, V. cholerae, Y. enterocolitica), 3 viruses (adenovirus
40/41, norovirus GI/GII, rotavirus A), and 3 amoeba/protozoa (‘parasites’: Giardia, Cryptospo-
ridium, Entamoeba histolytica). The GPP is a well-validated assay with high sensitivity and
specificity that has been tested across multiple countries [27–33]. Child stool specimens were
also assessed for 84 ARGs via a commercial qPCR ARG array (the Antibiotic Resistance Genes
Microbial DNA qPCR array, Qiagen, Valencia, CA, USA, ARGs in S1 Table), which has been
used previously to characterize ARGs in the human gut, environmental soil, and meat for con-
sumption in high-income settings [34–38]. Ethical approvals for stool and survey data collec-
tion were obtained from the Comite´ Nacional de Bioe´tica para a Sau´de, Ministe´rio da Sau´de
(333/CNBS/14), the Ethics Committee of the London School of Tropical Medicine and
Hygiene (reference # 8345), and the Institutional Review Board of the Georgia Institute of
Technology (protocol # H15160). Ethical committees approved the verbal consent procedures
because most respondent were illiterate. All consents were recorded on the survey question-
naire or tablet prior to initiating surveys. The MapSan trial was registered at ClinicalTrials.gov
(NCT02362932).
Study site
The study site comprised densely-populated, low-income neighborhoods of Maputo, Mozam-
bique described elsewhere [26,39]. Briefly, children lived in households organized in com-
pounds that generally shared a sanitation facility. Most households had access to a sanitation
facility that contained waste onsite, while few lacked access to basic sanitation facilities [39].
Children from these compounds had to be�1 month old to be enrolled in MapSan [39].
Surveys and observation
Data were collected on child, household, and compound demographics; water, sanitation, and
hygiene (WASH) practices; and household wealth by surveys and observation [39]. The child’s
mother was the target respondent for surveys about the child’s health and the household. If the
mother was unavailable, another parent or guardian was asked to respond to survey questions.
The head of compound, or their spouse, was the target respondent for surveys about the com-
pound itself. Observations of household conditions, WASH infrastructure, and the compound
overall were also completed. Household wealth was measured by an asset-based index specific
to and locally-validated in Mozambique [40].
Stool collection and analysis
Stool specimens were collected as described previously [39]. Briefly, caregivers were given dia-
pers or containers for collecting children’s stool with pre-labelled sample bags and to store col-
lected stool in a cool, dry place in the household. Stool specimens were picked up from the
household the following day, and transported on ice to the Mozambican Ministry of Health
(MISAU/INS) within 6 hours for storage at -80˚C. Specimens were then shipped on dry ice,
with temperatures monitored, to the Georgia Institute of Technology for storage at -80˚C until
analysis.
Stool specimens were analyzed by the GPP according to manufacturer’s instructions, using
the QIAcube HT platform and QIAamp 96 Virus QIAcube HT Kit (Qiagen, Hilden, Ger-
many). Extracted nucleic acids were stored at 4˚C and analyzed by GPP within 24 hours. Fur-
ther details on stool analysis for enteric pathogens can be found in Knee et al. [39].
For ARG assessment, DNA from whole stool was extracted using the Qiagen PowerFecal
Kit for Qiacube (Qiagen, Hilden, Germany). Extracted DNA was stored at -80˚C until use, and
underwent�1 previous freeze-thaw cycle before analysis. Total reaction volumes, including
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amount of Qiagen Microbial DNA Mastermix and target amount of DNA (500ng/array) were
set according to manufacturer’s instructions. Arrays were loaded and run on an ABI 7500
Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) following manufacturer’s
instructions or stored at -20˚C for up to 7 days until the run. Quantification cycle (Cq) values
of<34 indicated positive detects. Each sample had six pan-bacteria positive controls (to ensure
sufficient quantities of bacterial DNA) and three plate controls (tests for inhibitors via artificial
sequence and primers). Lower limits of quantification for most ARG targets in the assay (97%)
were<100 gene copies per reaction.
Aggregate ARG indices
Beyond individual ARG prevalence, ARGs detected in each child’s stool specimen were evalu-
ated by three aggregate measures: total ARGs, Shannon Index, and Inverse Simpson’s Index.
Total ARGs were calculated as the total number of positive wells (targets) detected per speci-
men. In ecological literature, diversity indices (Shannon Index [41] and Inverse Simpson’s
Index [42]) measure the richness of individual species (generally: [number of species repre-
sented]:[number of individuals in each species], thus higher numbers indicate greater diver-
sity) and each give different weights to dominant species. They have been used to quantify the
diversity of mobile genetic elements and ARGs in infants in high-income settings [43] and of
ARGs in environmental media (e.g. sewage sludge [44,45]). In this study, ARG groups (e.g.
aminoglycoside resistance, tetracycline resistance; β-lactamase resistance subdivided into
Ambler classes (class A-D [46])) represented the ‘species’ level, with number of targets detected
within each ARG group representing the ‘number of members of the species’ in ecological
terms.
Statistical analyses
All data were analyzed in R version 3.4.0 (R Foundation for Statistical Computing, Vienna,
Austria [47]) using the ‘lme4’ package for generalized linear models with random effects [48]
and the ‘vegan’ package for calculating Shannon and Inverse Simpson’s indices [49]. The
‘total ARG’ outcome, the number of ARGs detected, was analyzed using mixed-effects Poisson
regression, with a random effect for the child’s compound. Diversity indices were analyzed
using mixed-effects linear regression, with a random effect for the compound. Demographic,
WASH, and wealth risk factors that were tested for associations with these outcomes were
included as continuous or categorical variables. For categorical variables with >2 levels,
dummy variables were created: e.g. for sanitation, children in compounds with a pit latrine
were the referent group, compared with children in compounds with pour flush facilities
compared to them. All analyses were adjusted for round of enrollment. Enteric pathogen
risk factors (enteric pathogens detected in stool) were also adjusted for reported diarrhea to
encompass symptomatic enteric infections that may cause caregivers to seek care for the child
with antibiotics [2].
Results
Demographic characteristics and enteric infections
We assessed demographic characteristics and enteric pathogen carriage in study children by
surveys and stool specimen analysis, respectively (Table 1). All children were <14 months old
(average age of 8 months, standard deviation (SD): 3 months; Table 1a) and half (53%) were
female. Most children (80%) were breastfed at the time of survey, but only 17% of those
Antimicrobial resistance genes in Mozambican children
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Table 1. Demographic characteristics and enteric infections among children< 14 months old, Maputo,
Mozambique1.
a) Demographics Mean (standard deviation (SD)) or
N (%), Round 1
Mean (SD) or
N (%), Round 2
Mean (SD) or
N (%), all years
Age (months) 7.5 (3.2) 8.7 (2.8) 8.1 (3.0)
Female child2 33 (56%) 30 (50%) 63 (53%)
Child is breastfed 46 (77%) 50 (83%) 96 (80%)
Child is exclusively breastfed 12 (26%) 4 (8%) 16 (17%)
Wealth index (unitless, range: 0–1) 0.43 (0.13) 0.35 (0.14) 0.39 (0.14)
Type of toilet
Pit latrine 59 (98%) 30 (50%) 89 (74%)
Pour flush to septic tank 0 27 (90%) 27 (23%)
Pour flush to other 1 (2%) 3 (10%) 4 (3.3%)
b) Reported diarrhea
Diarrhea in last 7 days3 9 (18%) 8 (18%) 17 (18%)
Sought treatment for diarrhea 6 (67%) 3 (38%) 9 (53%)
c) Enteric pathogen detection (stool specimens)
Any pathogen 51 (85%) 48 (80%) 99 (83%)
Number of pathogens
0 9 (15%) 12 (20%) 21 (18%)
1 27 (45%) 20 (33%) 47 (39%)
2 15 (25%) 23 (38%) 38 (32%)
3 8 (13%) 4 (7%) 12 (10%)
4 0 0 0
5 1 (2%) 1 (2%) 2 (2%)
Bacterial pathogens4 43 (72%) 40 (67%) 83 (69%)
Number of bacterial pathogens
0 17 (28%) 20 (33%) 37 (31%)
1 29 (48%) 23 (38%) 52 (43%)
2 13 (22%) 15 (25%) 28 (23%)
3 1 (2%) 1 (2%) 2 (2%)
4 0 1 (2%) 1 (1%)
Parasitic pathogens5 13 (22%) 10 (17%) 23 (19%)
Number of parasitic pathogens
0 47 (78%) 50 (83%) 97 (81%)
1 11 (18%) 9 (15%) 20 (17%)
2 2 (3%) 1 (2%) 3 (3%)
Viral pathogens6 13 (22%) 11 (18%) 24 (20%)
Number of viral pathogens
0 47 (78%) 49 (82%) 96 (80%)
1 13 (22%) 10 (17%) 23 (19%)
2 0 1 (2%) 1 (1%)
1n = 60 children enrolled in round 1 (February 2015-February 2016 enrollment) and 60 children enrolled in round 2
(March 2016-April 2017 enrollment);
2Sex of the child was not able to be ascertained for 1 child;
394/120 children had dates of survey and stool collection within 7 days of each other, and thus were included in
analyses for diarrhea;
4Bacterial pathogens included in Luminex Assay: Campylobacter spp., C. difficile, V. cholerae, enterotoxigenic E. coli
(ETEC), E. coli O157, Salmonella enterica, Shigella spp., Shiga-toxin producing E. coli (STEC), Y. pestis;
5Parasitic pathogens included in Luminex Assay: Cryptosporidium spp., Giardia spp., E. histolytica;
6Viral pathogens included in Luminex Assay: adenovirus 40/41, norovirus, rotavirus
https://doi.org/10.1371/journal.pone.0225464.t001
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breastfed were exclusively breastfed. Most households had access to a pit latrine (74%), and
mean value for the (unitless, ranging from 0–1) wealth index was 0.39.
All analyses involving reported diarrhea were limited to the 94/120 children that had sur-
veys of reported diarrhea collected within ±7 days of the stool specimen to ensure biological
plausibility of concurrence of symptoms and pathogen carriage. About 18% of caregivers
reported the child had diarrhea within the past week, with half reporting having sought care
for the diarrhea (Table 1b). However, among all children, 83% had�1 pathogen detected in
their stool, and 44% had multiple pathogens detected (Table 1c). Bacterial pathogens were
most commonly detected (69%), followed by viruses (20%) and parasites (19%). The most
commonly detected bacterial pathogens were Salmonella enterica (51%), ETEC (34%), and C.
difficile (22%, S1 Table). Giardia spp. (78%) was the most commonly detected parasitic patho-
gen, while norovirus (79%) was the most common viral pathogen (S1 Table).
ARG outcomes in children
We assessed ARGs in stool specimens by group and using aggregate metrics for total genes
and diversity (Table 2). Though ARGs were detected in all specimens, the most commonly
detected ARGs conferred resistance to a) macrolides, lincosamides, and streptogramin b
(MLS, 100%); b) tetracyclines (98%); c) β-lactams (94%); and d) aminoglycosides (84%)
(Table 2a). On average, 3.1 of 5 MLS ARGs tested, 1.8 of 2 tetracycline ARGs tested, 4.6 of 55
β-lactam ARGs tested, and 1.1 of 5 aminoglycoside ARGs tested were detected in each sample.
About half of children (48%) had ARGs conferring resistance to fluoroquinolones, and 38%
had ARGs conferring resistance to vancomycin. ARGs conferring multidrug resistance were
not common (<1%).
Prevalences of individual ARGs are shown in S2 Table. Of the 84 ARGs assessed per child,
9 (11%) were detected in >50% of children: 1 aminoglycoside ARG (aadA1); 3 β-lactamase
ARGs (SHV, SHV(156G), and SHV(238G240E)); 3 MLS ARGs (ermA, ermB, and mefA); and 2
tetracycline ARGs (tetA and tetB). Another 19 ARGs (23%) were detected in�10% of children:
1 aminoglycoside ARG (aacC2), 11 β-lactamase ARGs (mecA, CTX-M-8, CTX-M-9, SHV
Table 2. Antimicrobial Resistance Gene (ARG) detection by resistance group in children <14 months old, Maputo, Mozambique.
All samples Per sample
a) Resistance group (# ARGs in group tested) Samples positive for� 1 ARG (%) Avg. number of positive ARGs (standard deviation) Range of ARGs detected
Aminoglycoside (5) 101 (84.2%) 1.13 (0.67) 0–3
β-lactamase (55) 113 (94.2%) 4.58 (2.83) 0–14
Class A β-lactamase (22) 96 (80.0%) 2.74 (1.75) 0–7
Class B β-lactamase (9) 33 (27.5%) 0.29 (0.49) 0–2
Class C β-lactamase (11) 75 (62.5%) 1.24 (1.32) 0–6
Class D β-lactamase (13) 29 (24.2%) 0.31 (0.65) 0–4
Erythromycin (1) 0 (0%) 0 0
Fluoroquinolone (7) 58 (48.3%) 0.87 (1.14) 0–4
Macrolide, lincosamide, streptogramin b (5) 120 (100%) 3.09 (1.08) 1–5
Multidrug (2) 1 (0.8%) 0.02 (0.18) 0–2
Tetracycline (2) 118 (98.3%) 1.78 (0.45) 0–2
Vancomycin (2) 45 (37.5%) 0.38 (0.49) 0–1
b) Aggregate metrics Mean (SD) Median (Range)
Total ARGs 12.4 (4.5) 12 (4–28)
Shannon Index 1.6 (0.3) 1.6 (0.6–2.0)
Inverse Simpson’s Index 4.5 (1.1) 4.5 (1.6–6.9)
https://doi.org/10.1371/journal.pone.0225464.t002
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(156D), ccrA, ACT-5/7, ACT-1, DHA, LAT, MIR, and OXA-51 variants), 4 fluoroquinolone
ARGs (QnrB-1, QnrB-4, QnrB-8, and QnrS), 2 MLS ARGs (ermC and msrA), and 1 vancomy-
cin ARG (vanC).
On average, 12 ARGs were detected per child (range: 4–28, Table 2b). Average Shannon
Index was 1.6 (range: 0.6–2), while average Inverse Simpson’s Index was 4.5 (range: 1.6–6.9).
Unadjusted associations between demographic and enteric pathogen risk
factors and ARG outcomes
We assessed associations between demographic or enteric pathogen risk factors and ARG out-
comes by regression techniques with a random effect for the compound (Table 3). Stool speci-
mens collected from children enrolled in round 2 had significantly more ARGs detected than
from children enrolled in round 1 (risk ratio (RR): 1.21, 95% confidence interval (CI): 1.07,
1.38), but diversity indices did not vary significantly by round. Improved household wealth
(10 percentage point change in the wealth index) was associated with fewer total ARGs (RR:
0.96, 95% CI: 0.92, 1.00). Children in households with septic tanks had moderately more
ARGs detected than those in households with pit latrines (RR: 1.17, 95% CI: 1.00, 1.36).
Presence of�1 bacterial pathogen in stool was associated with 16% more ARGs detected
(RR: 1.16, 95% CI: 1.02, 1.34). Each additional bacterial pathogen detected was associated
with a 10% increase in ARGs (RR: 1.10, 95% CI: 1.01, 1.19). Conversely, parasitic pathogen
detection was associated with 17% fewer ARGs (RR: 0.83, 95% CI: 0.70, 0.96). Pathogen detec-
tion was not associated with differences in diversity indices.
Table 3. Unadjusted associations between demographic and enteric pathogen-related characteristics and ARG
outcomes among children < 14 months old, Maputo, Mozambique.
Risk factor Total ARGs
RR1 (95% CI2)
Shannon Index
β3 (95% CI2)
Inverse Simpson’s Index
β3 (95% CI2)
Round (2 vs. 1 (ref.)) 1.21 (1.07, 1.38) -0.04 (-0.14, 0.07) -0.06 (-0.48, 0.35)
Age (months) 1.01 (0.99, 1.04) 0.00 (-0.02, 0.02) -0.01 (-0.0, 0.07)
Female child 0.98 (0.86, 1.09) 0.06 (-0.05, 0.17) 0.29 (-0.13, 0.71)
Child is breastfed 1.04 (0.88, 1.22) -2.9 x 10−3 (-0.14, 0.13) 0.06 (-0.45, 0.57)
Wealth index4 0.96 (0.92, 1.00) -0.01 (-0.05, 0.03) -0.06 (-0.20, 0.08)
Type of sanitation
Pit latrine Ref. Ref. Ref.
Pour flush (to septic) 1.17 (1.00, 1.36) -0.04 (-0.17, 0.09) -0.12 (-0.65, 0.38)
Pour flush to (other) 1.05 (0.82, 1.30) 0.11 (-0.08, 0.31) 0.30 (-0.41, 1.02)
Reported diarrhea4 0.87 (0.71, 1.05) 0.01 (-0.13, 0.18) -0.04 (-0.61, 0.57)
Any pathogen 1.07 (0.90, 1.25) -0.01, (-0.14, 0.15) -3.3 x 10−3 (-0.60, 0.50)
Number of pathogens 1.01 (0.94, 1.08) 9.2 x 10−4 (-4.9 x 10−2, 0.05) 0.03 (-0.16, 0.23)
Any bacterial pathogen 1.16 (1.02, 1.34) 0.04 (-0.07, 0.16) 0.21 (-0.24, 0.66)
Number of bacterial pathogens 1.10 (1.01, 1.19) 8.2 x 10−3 (-0.06, 0.07) 0.07 (-0.20, 0.35)
Any parasitic pathogen 0.83 (0.70, 0.96) 0.04 (-0.11, 0.18) 0.12 (-0.43, 0.67)
Number of parasitic pathogens 0.83 (0.71, 0.95) 0.03 (-0.08, 0.14) 0.08 (-0.34, 0.46)
Any viral pathogen 0.88 (0.74, 1.04) -0.08 (-0.20, 0.06) -0.26 (-0.75, 0.27)
Number of viral pathogens 0.93 (0.80, 1.06) -0.06 (-0.19, 0.05) -0.21 (-0.68, 0.34)
1Risk ratio estimated by mixed effects Poisson regression, with a random effect for compound;
2Confidence interval;
3Estimate is from mixed effects linear regression for the diversity metric;
4Limited to children whose survey for self-reported diarrhea was�7 days from stool specimen collection (n = 94)
https://doi.org/10.1371/journal.pone.0225464.t003
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Adjusted associations between demographic and enteric pathogen risk
factors and ARG outcomes
We assessed associations between demographic or enteric pathogen carriage and ARG out-
comes adjusted by round (Table 4). Adjustment for reported diarrhea for enteric pathogen
risk factors—as initially designed—was instead conducted as a sensitivity analysis (S3 Table),
given the 22% loss of observations from non-concurrent assessment of diarrhea and collection
of stool. The wealth index was not significantly associated with total ARGs when adjusting for
round (Table 4). Adjusting for round, detection of�1 bacterial pathogen in stool was associ-
ated with increased total ARGs (RR: 1.18, 95% CI: 1.02, 1.37), with an association of 9% more
ARGs per bacterial pathogen detected (RR: 1.09, 95% CI: 1.01, 1.17). Detection of parasitic
pathogens was associated with 16% fewer ARGs (RR: 0.84, 95% CI: 0.71, 0.99). Sensitivity anal-
ysis indicated no modeled estimates of enteric pathogen risk factors for total ARGs were mean-
ingfully attenuated (maximum attenuation: 8% of the original effect estimate) when also
adjusted for reported diarrhea (and therefore limited to the 94 children with surveys for
reported diarrhea�7 days from stool specimen collection) and most were strengthened
(S3 Table).
Discussion
We assessed the prevalence and diversity of ARGs as our outcome, and 1) poor sanitation and
other environmental risk factors; and 2) enteric pathogen carriage; in children (<14 months
Table 4. Adjusted1 associations between demographic and enteric pathogen-related characteristics and ARG out-
comes among children< 14 months old, Maputo, Mozambique.
Risk factor Total ARGs
RR2 (95% CI3)
Shannon Index
β4 (95% CI3)
Inverse Simpson’s Index
β4 (95% CI3)
Age (months) 1.01 (0.99, 1.03) -3.8 x 10−4 (-0.02, 0.02) 4.7 x 10−3 (-0.08, 0.06)
Female child 0.99 (0.87, 1.11) 0.06 (-0.05, 0.16) 0.29 (-0.08, 0.74)
Child is breastfed 1.02 (0.87, 1.22) 8.6 x 10−4 (-0.13, 0.14) 0.07 (-0.51, 0.37)
Wealth index5 0.98 (0.93, 1.03) -0.01 (-0.06, 0.02) -0.07 (-0.23, 0.09)
Type of sanitation
Pit latrine Ref. Ref. Ref.
Pour flush (to septic) 1.04 (0.86, 1.24) -0.02 (-0.17, 0.13) -0.11 (-0.65, 0.55)
Pour flush (to other) 1.01 (0.79, 1.27) 0.11 (-0.06, 0.31) 0.30 (-0.39, 1.07)
Reported diarrhea5 0.88 (0.71, 1.08) 0.01 (-0.14, 0.16) -0.04 (-0.66, 0.56)
Any pathogen 1.08 (0.92, 1.32) -0.01 (-0.14, 0.13) -0.01 (-0.60, 0.53)
Number of pathogens 1.01 (0.95, 1.08) -4.7 x 10−4 (-0.06, 0.05) 0.03 (-0.17, 0.24)
Any bacterial pathogen 1.18 (1.02, 1.37) 0.03 (-0.08, 0.16) 0.21 (-0.31, 0.66)
Number of bacterial pathogens 1.09 (1.01, 1.17) 0.01 (-0.05, 0.07) 0.07 (-0.19, 0.31)
Any parasitic pathogen 0.84 (0.71, 0.99) 0.04 (-0.09, 0.17) 0.12 (-0.49, 0.67)
Number of parasitic pathogens 0.84 (0.72, 0.95) 0.03 (-0.09, 0.15) 0.08 (-0.41, 0.54)
Any viral pathogen 0.89 (0.75, 1.04) -0.08 (-0.20, 0.05) -0.26 (-0.83, 0.26)
Number of viral pathogens 0.93 (0.80, 1.07) -0.07 (-0.19, 0.07) -0.21 (-0.66, 0.27)
1All estimates adjusted for round;
2Risk ratio estimated by mixed effects Poisson regression, with a random effect for compound;
3Confidence interval;
4Estimate is from mixed effects linear regression for the diversity metric;
5Limited to children whose survey for self-reported diarrhea was�7 days from stool specimen collection (n = 94)
https://doi.org/10.1371/journal.pone.0225464.t004
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old) in dense, low-income compounds in Maputo, Mozambique. Total ARGs detected from
stool using an 84-target array varied from 4–28 per stool specimen. The most common ARGs
detected were associated with resistance to MLS, tetracyclines, β-lactams, and aminoglyco-
sides. We did not observed significant direct associations between sanitation facilities and
ARGs, though sanitation conditions were poor overall and therefore the study’s setting made
it impossible to examine a wider range of WASH conditions. However, the total number of
ARGs detected in a stool specimen was associated with the presence and number of bacterial
pathogens detected in stool and inversely associated with presence of parasitic pathogens
(mostly Giardia spp.), suggesting potential indirect links with WASH risk factors through
enteric pathogen exposure. Differences in associations with risk factors by metric (total ARGs
vs. diversity measures) may also warrant further investigation of these outcomes.
This study provides important evidence of the background carriage of ARGs in the develop-
ing gut of children in a low-income, urban environment of an LMIC and quantifies risk factors
for ARG detection from the environment and concurrent enteric pathogen carriage. Although
there are no studies—to our knowledge—focusing on children under 1 year of age in LMIC
settings, these data are consistent with evidence from high-income settings of prevalent coloni-
zation of ARGs conferring resistance to aminoglycoside, tetracycline, or β-lactam antibiotics
in the early infant gut [50–55].
In addition to the importance of ARG fate and transport in the environment and the
child gut, the ARGs detected have potential clinical consequences in this setting. Most ARGs
detected conferred resistance to MLS, tetracycline, β-lactam, or aminoglycoside antibiotics,
with about 50% of children also having ARGs conferring resistance to fluoroquinolones.
Mozambican guidelines for treatment of enteric infections in children <2 years old suggest
ampicillin and gentamicin [3], which may have resistance conferred via β-lactamase [56] and
aminoglycoside [57] ARGs, among others. Among children >2 years, chloramphenicol (a flu-
oroquinolone) is suggested [3]. Pediatric ARG surveillance is rare outside of clinical settings;
however, our results indicate similarly high prevalence (�85%) of tetracycline resistance genes
(tetA, tetB) in children in this study as in previous clinical investigations of resistant Shigella
and Salmonella in feces from children <5 with moderate-to-severe diarrhea in rural Mozam-
bique [58]. Further, CTX-M gene prevalence (about 10%)—associated with extended-spec-
trum β-lactamase-producing E. coli and other coliforms—was lower in our study than in a
recent assessment of E. coli and Klebsiella spp. in Mozambican university students (66%) [59].
However, given challenges in the interpretation of ARG detection as compared with pheno-
typic resistance [23,25], we underscore that molecular ARG detection in stool alone, even in
the presence of an enteric pathogen, does not imply that the antimicrobial would not be useful
for treatment of an enteric infection, nor that the pathogen is phenotypically resistant to it.
There are numerous potential sources of ARGs for the developing infant and child’s gut.
Studies in high-income settings suggest infants may acquire ARGs from their mother—both
with and without recent maternal antibiotic use—before, during, and just after birth, especially
tetracycline and β-lactamase ARGs [43,50,51,53]. Specifically, the type of delivery (e.g.
increased detection of tetracycline ARGs from the mother’s vagina in infants born vaginally
vs. Cesarean section [53]), breast milk [43], and skin contact [43] may be important sources of
mother-to-child ARG transmission. Longitudinal assessment of the infant gut resistome sug-
gests environmental contributions to ARGs in the first year of life [60]. Notably, ARGs colo-
nizing the gut may also be housed in commensal bacteria [61], suggesting both pathogenic and
commensal bacterial exposures as sources.
Environmental exposure measures (e.g. type of sanitation) were not directly associated with
pediatric ARG detection although emerging evidence suggests WASH facilitates the develop-
ment and environmental dispersion of AR organisms at regional or national scales [5–8].
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WASH conditions in study compounds were generally poor [39] and may not have improved
sufficiently—even with the introduction of septic tanks—to observe or detect differences in
ARGs. Given this evidence, local or site-specific sources, dynamics, and exposure pathways for
AR organisms in these environments—especially with decentralized or onsite sanitation sys-
tems—are poorly understood. One study in rural Bangladeshi households with prevalent ani-
mal and human fecal contamination concluded that the physical and chemical characteristics
of the environment (for example, water content of soil) were more important than household
WASH characteristics in the detection of soil E. coli, many of which were pathogenic and car-
ried clinically-relevant ARGs [62]. These findings suggest that other physical and chemical
conditions of the household environment in Maputo, which we did not measure and could
have changed with the introduction of water-based septic systems in round 2 in the MapSan
trial [26], may also have modified WASH-AR organism relationships. Such change in environ-
mental conditions with the introduction of septic systems may explain why significantly more
ARGs were detected in round 2 children than those in round 1. Importantly, because septic
systems were introduced for round 2, it was difficult to separate their associations with ARGs
from the significantly higher detection of ARGs in round 2 alone, especially given small sample
sizes. This could explain why septic tanks were associated with moderately higher ARG detec-
tion in unadjusted models but not in those adjusted for round.
Associations between total ARGs and carriage of enteric bacterial pathogens, including
modest evidence of dose-response between total ARGs and number of bacterial pathogens,
suggest these pathogens as potential vectors of ARGs and, subsuquently, indirect links with
poor WASH. Data from clinical surveillance in Mozambique suggest phenotypic resistance to
first- and second-line treatments for enteric infections is high among children <5 presenting
with diarrhea due to enteric bacteria (e.g. Salmonella enterica, Shigella spp., ETEC [58,63]). AR
in human and animal enteric pathogens is also increasing in the region [64]. Correspondingly,
carriage of ARGs by enteric bacteria in the environment may concurrently increase, suggesting
that continual high levels of exposure to such bacteria may transfer genotypic, and potentially
phenotypic, resistance. Notably, the direction of association could also be reversed: that is,
prevalent clinical treatment of pediatric diarrhea—irrespective of etiologic agent—with antibi-
otics and widespread non-prescription antimicrobial use in LMICs [2,3] could drive antimi-
crobial treatment, and subsequent selection pressure and ARG transfer. However, because we
used molecular (and not culture-based) techniques and this was a cross-sectional assessment,
we cannot ascertain whether the specific enteric pathogens detected in a child’s stool were also
carrying the specific ARGs that were concurrently detected. Pediatric exposure to antimicro-
bial treatment for other infections (e.g. respiratory infections), may also be significant: in
Mozambique, invasive pneumococcal disease, which affects 416/100,000 child-years, is highest
in children <2 and requires treatment with penicillin and chloramphenicol [3]. Thus, concur-
rent antimicrobial use that we did not assess in our survey may contribute to ARG carriage.
Inverse associations between parasites—primarily Giardia spp.—and total ARGs may
indicate that previous evidence suggesting bacterial colonization of the gut is modified with
concurrent Giardia spp. carriage extends to ARG transfer, though this finding would be the
first of its kind and should be investigated further. Although the role of Giardia spp. in the
incidence and severity of co-infecting agents is still being studied, in vivo mouse studies and
in vitro studies of human cells suggest Giardia spp. may modify host immune response to
bacterial pathogens, including reducing inflammatory responses and shortening bacterial
attachment to gut lining [65–67]. These Giardia-bacteria interactions may reduce the inci-
dence of symptoms in the host, and potentially could also—directly or indirectly—play a
role in reducing colonization and subsequent ARG transfer via various molecular mecha-
nisms in the human gut [68]. Conversely, if antibiotic exposure from treatment of diarrheal
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infections drives ARG transfer in this environment, then the well-documented reduction
in diarrhea associated with Giardia spp. infection [67] may also explain the reductions in
ARGs detected.
Measures of gut ARG diversity were largely not associated with demographic or
enteric pathogen risk factors, yet may be an important additional metric worth further
study. The diversity of ARGs can provide important information about environmental
exposures and changes in the gut, as in previous molecular and metagenomic analyses of
gut bacteria and ARGs [43–45,69,70]. Thus, while we were not able to fully examine ARG
diversity in this exploratory analysis, these metrics may warrant further assessment in future
studies.
There are several limitations of this analysis. Importantly, given the absence of risk factor
analyses for exposure to AR pathogens or ARGs in these settings, we used an exploratory
approach that warrants caution and further investigation of significant associations detected
using targeted, hypothesis-testing approaches. As noted, we were unable to quantify other
potential environmental pathways of exposure to ARGs, such as food from animals treated
with antimicrobials [71,72]. Although we adjusted for reported diarrhea as a proxy for recent
antimicrobial treatment in a sensitivity analysis and did not observe evidence of confounding,
we were unable to directly quantify the recent antibiotic or other clinical history of the child,
an important potential risk factor [73]. Finally, we used a commercial array to assess pediatric
AR profiles and test existing multi-target qPCR technologies for population-level ARG quanti-
fication in a low-income setting; however, the array may be more appropriate for clinically-
relevant ARGs in high-income countries and therefore may not have comprised all ARGs of
importance to children’s guts in LMICs. Metagenomic approaches, though costly, may be a
useful alternative with enhanced capacity (through access to ARG databases) to characterize
the complete molecular ‘resistome’ and identify key ARGs of public health importance with
environmental transmission [70,74–76].
We observed prevalent ARGs that could confer resistance to first-line drugs for multiple
infections, including enteric infections, in the guts of young children (<14 months old) in a
densely-populated, low-income, urban setting. Environmental risk factors—including poor
sanitation—were not directly associated with ARG detection in childrens’ guts; however,
enteric bacterial pathogen carriage in stool was associated with increases in ARGs detected.
This analysis provides important early data to begin elucidating the role that WASH—directly
or indirectly—may play in transmission of AR in children in LMICs.
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